Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P8-GII.8/NV-23-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-004. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P5-GI.5/NV-23-006. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P3-GI.3/NV-23-007
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P7-GII.6/NV-23-008.
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.10/NV-23-009.
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P8-GII.8/NV-23-010.
. Material 10-20% fecal material in virus culture medium.
Piece of cat spleen infected by Feline Leukemia Virus (FeLV) (tested and negative for feline immunodeficiency virus-FIV and feline panleukopoenia virus-FPV).
Piece of cat organ infected by Feline Leukemia Virus (FeLV) (tested and negative for feline immunodeficiency virus-FIV and feline panleukopoenia virus-FPV).
This SARS-CoV-2 strain was isolated from a COVID-19 patient from Slovakia in September 2023. The virus belongs to the FY.5 lineage (Alias of XBB.1.22.1.5; Omicron VOC).
This SARS-CoV-2 strain was isolated from a COVID-19 patient from Slovakia in March 2023. The virus belongs to the XBB.1.5 lineage (Omicron VOC). The virus is preserved in Viral Storage Medium (-80 °C).
This SARS-CoV-2 strain was isolated from a COVID-19 patient from Slovakia in February 2023. The virus belongs to the BA.5.2.35 lineage (alias of B.1.1.529.5.2.35; Omicron VOC).
This SARS-CoV-2 strain was isolated from a COVID-19 patient from Slovakia in February 2023. The virus belongs to the BQ.1.1.10 lineage (alias of B.1.1.529.5.3.1.1.1.1.1.1.10; Omicron VOC).
Human influenza A(H1N1)pdm09 virus isolated in 2022/2023 season in Greece. Infectious cell culture supernatant preserved in Viral Storage Medium -80°C.
